实用肿瘤学杂志 ›› 2016, Vol. 30 ›› Issue (3): 225-228.doi: 10.11904/j.issn.1002-3070.2016.03.006

• 论著 • 上一篇    下一篇

DCE-MRI 4D-Tissue技术定量参数评估宫颈癌放化疗疗效的预测价值

刘伟锋1, 徐凡2, 吴梅1   

  1. 1.广州医科大学附属广州市第一人民医院放射科(广州 510180),2.广州红十字会医院放射科
  • 收稿日期:2015-12-14 出版日期:2016-06-20 发布日期:2016-07-01
  • 通讯作者: 吴梅,E-mail:may9@sina.com
  • 作者简介:刘伟锋,男,(1976-),硕士,副主任医师,从事影像诊断的研究
  • 基金资助:
    广东省科技厅科技计划项目(20120318056);广东省科技厅公益研究与能力建设专项资金项目(2014A020212030)

The predictive value of therapeutic effect with concurrent chemoradiation for cervical carcinoma by the quantitative analysis of DCE-MRI 4D-Tissue technology

LIU Weifeng1,XU Fan2,WU Mei1   

  1. 1.Department of Radiology,Guangzhou Medical University Affiliated Guangzhou First People′s Hospital,Guangzhou 510108,China;
    2.Department of Radiology,Guangzhou Red Cross Hospital
  • Received:2015-12-14 Online:2016-06-20 Published:2016-07-01

摘要: 目的 探究应用3.0T动态增强磁共振功能成像(DCE-MRI)定量参数评估宫颈癌放化疗疗效的价值。方法 选取2013年1月—2015年3月在我院行同步放化疗,并在治疗前、治疗末行DCE-MRI扫描的30例子宫颈癌患者。测量所有病例放化疗前后的DCE-MRI参数Ktrans、Kep、Ve的平均值,并与治疗末肿瘤消退率进行Spearman相关性分析。结果 肿瘤以Ⅲ型曲线为主,疗前:Ⅰ型1例(3.33%),Ⅱ型3例(10%),Ⅲ型26例(86.67%);疗末:Ⅰ型5例(16.67%),Ⅱ型13例(43.33%),Ⅲ型12例(40%);子宫肌层以Ⅰ型曲线为主,疗前:Ⅰ型18例(60%),Ⅱ型12例(40%);疗末:Ⅰ型16例(53.33%),Ⅱ型14例(46.67%)。治疗末肿瘤消退率与治疗前肿瘤组的平均Ktrans、Kep、Ve均呈正相关(r:0.124~0.668,P<0.01~0.031)。结论 治疗末肿瘤消退率与治疗前肿瘤组的平均Ktrans、Kep、Ve均呈正相关。DCE-MRI定量参数可以预测宫颈癌的治疗敏感度,有望为宫颈癌的个体化治疗提供依据。

关键词: 宫颈癌, 动态增强磁共振功能成像, 同步放化疗, 疗效, 预测

Abstract: Objective To explore the predictive value of the therapeutic effect with concurrent chemoradiation about cervical carcinoma through the quantitative analysis of 3.0T dynamic enhanced MRI(DCE-MRI).Methods Thirty cases of cervical carcinoma with concurrent chemoradiation in our hospital(Guangzhou first people′s hospital)from January 2013 to March 2015 were included in our study.All the cases had been confirmed by pathology.The mean value of DCE-MRI parameters including Ktrans,Kep,Ve was measured in all cases and the Spearman analysis was made between them and tumor regression rate.Results Before treatment tumor tissue and uterine muscle TIC curve:The tumors were given priority to type III curve,before the treatment:1 case of type I(3.33%),3 cases of type II(10%),26 cases of type III(86.67%),at the end of the treatment:5 cases of type I(16.67%),13 cases of type II(43.33%),12 cases of type III(40%);uterine muscles were given priority to type I curve,before the treatment:18 cases of type I(60%),12 cases of type II(40%),at the end of the treatment:16 cases of type I(53.33%),14 cases of type II(46.67%).Tumor regression rate after treatment had positive correlation with mean value of Ktrans,Kep and Ve for tumors before treatment(r:0.124~0.668,P<0.01~0.031).Conclusion Tumor regression rate has positive correlation with mean value of Ktrans,Kep and Ve for tumors before treatment.DCE-MRI quantitative parameters can predict the treatment effect of cervical carcinoma,which is expected to provide a basis for the individualized treatment of cervical carcinoma.

Key words: Cervical carcinoma, DCE-MRI, Concurrent chemoradiation, Therapeutic effect, Prediction

中图分类号: